Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Psychiatry

• Publication date

  2007-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.mp.4001926PMID 17146470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment

  2007cited by this paper
• Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder

  2006cited by this paper
• Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants

  2006cited by this paper
• "A gene for...": the nature of gene action in psychiatric disorders.

  2006cited by this paper
• Serotonin transporter gene variants and behavior: a comprehensive review.

  2006cited by this paper
• Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

  2006cited by this paper
• Directional Positive Selection on an Allele of Arbitrary Dominance

  2006cited by this paper
• Effects of the Serotonin Type 2A, 3A and 3B Receptor and the Serotonin Transporter Genes on Paroxetine and Fluvoxamine Efficacy and Adverse Drug Reactions in Depressed Japanese Patients

  2006cited by this paper
• Meta‐analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders

  2005cited by this paper
• Pharmacogenetics in the treatment of depression: pharmacodynamic studies

  2005cited by this paper
• Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis

  2005cited by this paper
• Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies.

  2005cited by this paper
• Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?

  2005cited by this paper
• Sequence analysis of the serotonin transporter and associations with antidepressant response.

  2005cited by this paper
• Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism

  2005cited by this paper
• A gene for...": the nature of gene action in psychiatric disorders.

  2005cited by this paper
• Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.

  2005cited by this paper
• Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review

  2004cited by this paper
• The pharmacogenomics of selective serotonin reuptake inhibitors

  2004cited by this paper
• Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.

  2004cited by this paper
• Meta-analysis of genetic association studies.

  2004cited by this paper
• Investigation of serotonin-related genes in antidepressant response

  2004cited by this paper
• Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

  2004cited by this paper
• The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder

  2004cited by this paper
• Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression.

  2004cited by this paper
• Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment

  2004cited by this paper
• 5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated With Citalopram in a 12-Weeks Follow Up Study

  2003cited by this paper
• Diagnosis and definition of treatment-resistant depression.

  2003cited by this paper
• Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline.

  2003cited by this paper
• Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

  2002cited by this paper
• Treatment of Depression: Bridging the 21st Century

  2002influential reference
• Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

  2002cited by this paper
• Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome.

  2002cited by this paper
• Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression.

  2001cited by this paper
• Treatment of depression : bridging the 21st century

  2001cited by this paper
• Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs.

  2001cited by this paper
• Transmission/disequilibrium tests for quantitative traits

  2001cited by this paper
• The economic and social burden of depression.

  2001cited by this paper
• Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.

  2001cited by this paper
• Serotonin transporter gene polymorphism and antidepressant response

  2000cited by this paper
• The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

  2000cited by this paper
• Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene.

  2000cited by this paper
• Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression

  2000cited by this paper
• Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.

  1999cited by this paper
• Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

  1998cited by this paper
• Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder

  1997cited by this paper
• Transmission-disequilibrium tests for quantitative traits.

  1997cited by this paper
• Allelic Variation of Human Serotonin Transporter Gene Expression

  1996cited by this paper
• Definition and epidemiology of treatment-resistant depression.

  1996cited by this paper
• The economic burden of depression in 1990.

  1993cited by this paper
• The economic burden of depression.

  1986cited by this paper
• Identification of true drug response to antidepressants. Use of pattern analysis.

  1984cited by this paper

• The Genetic Mosaic of Depression: Linking Polymorphisms to Neuroplasticity and Stress Regulation.

  2026cites this paper
• Polymorphic variants of SLC6A4 and TPH1 genes as predictors of sertraline efficacy and safety in patients with mixed anxiety-depressive disorder: a pilot study

  2025cites this paper
• Mice Lacking the Serotonin Transporter do not Respond to the Behavioural Effects of Psilocybin.

  2025cites this paper
• Molecular genetic basis of the primary emotions in young adults: an exploratory analysis of genetic polymorphisms across dopamine, serotonin, oxytocin, endogenous opioid, and neurotrophic factor pathways

  2025cites this paper
• Exploring the association between serotonin transporter promoter region methylation levels and depressive symptoms: a systematic review and multi-level meta-analysis

  2025cites this paper
• The Effects of Prophylactic Fluoxetine Administration on Post-Stress Depressive-Like Behavior in Mice

  2025cites this paper
• Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder

  2024cites this paper
• The additive effect between citalopram and muscimol upon induction of antinociceptive effect in male mice

  2024cites this paper
• Focal pharmacological manipulation of serotonin signaling in the amygdala does not alter social behavior

  2024cites this paper
• Analysis of SLC6A4 (5 ‑HTTLPR) gene polymorphism depending on clinical features and efficacy of therapeutic and rehabilitation measures in patients with psychostimulant addiction

  2024cites this paper
• Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression

  2024cites this paper
• Challenges and Opportunities in Managing Geriatric Depression: The Role of Personalized Medicine and Age-Appropriate Therapeutic Approaches

  2024cites this paper
• Psychiatric comorbidities of migraine.

  2024cites this paper
• The Serotonin Hypothesis: An Umbrella Review of Depression Evidence

  2024cites this paper
• Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone

  2023cites this paper
• Genetics of antidepressant response and treatment-resistant depression.

  2023cites this paper
• The Lack of Influence of Homozygous Long Allele of the 5-HTTLPR Gene on the Severity of Alcohol Craving During 6 Weeks of Rehab Hospitalisation in Comparison to Not Homozygous and Homozygous Short Alleles – Preliminary Report

  2023cites this paper
• Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.

  2023cites this paper
• Disruptive mutations in the serotonin transporter associate serotonin dysfunction with treatment-resistant affective disorder

  2023cites this paper
• Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review

  2023cites this paper
• Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression

  2022cites this paper
• PSYCHOPHARMACOLOGICAL TARGETS IN PERSONALIZED PSYCHIATRY

  2022cites this paper
• Precision medicine in mood disorders

  2022cites this paper
• Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder

  2022cites this paper
• Additive serotonergic genetic sensitivity and cortisol reactivity to lab-based social evaluative stress: Influence of severity across two samples.

  2022cites this paper
• Identifying obesity phenotypes: The role of personality, temperament, appetitive traits, and hyperpalatable food consumption

  2022cites this paper
• Birth of the blues: emotional sound processing in infants exposed to prenatal maternal depression

  2022cites this paper
• Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials.

  2022cites this paper
• [Current methods for predicting therapeutic response in patients with depressive disorders].

  2022cites this paper
• Early life stress and the role of environmental and molecular moderators in the ontology of pathological and resilient behavioral phenotypes

  2022cites this paper
• fMRI Neurofeedback as Treatment for Depression

  2021cites this paper
• Electrophysiological Biomarkers for Mood Disorders

  2021cites this paper
• Functional Connectome in Bipolar Disorder

  2021cites this paper
• Neuroanatomical Findings in Unipolar Depression and the Role of the Hippocampus

  2021cites this paper
• Personalized Pharmacotherapy: A Historical Perspective on the Pharmacogenomics of Depression

  2021cites this paper
• Neuroimaging Brain Inflammation in Mood Disorders

  2021cites this paper
• Neuroimaging Biomarkers in Pediatric Mood Disorders

  2021cites this paper
• An Overview of Machine Learning Applications in Mood Disorders

  2021cites this paper
• Functional Near-Infrared Spectroscopy Studies in Mood Disorders

  2021cites this paper
• Intervention options: Depression & Cardiovascular Disease during Covid-19 Pandemia

  2021cites this paper
• Treatment-Resistant Depression Revisited: A Glimmer of Hope

  2021cites this paper
• Maternal Serotonin Reuptake Inhibitor Antidepressants Have Acute Effects on Fetal Heart Rate Variability in Late Gestation

  2021cites this paper
• Brain Imaging Methods in Mood Disorders

  2021cites this paper
• GAISENOK: PANDEMIC OF FEAR

  2021cites this paper
• Brain Imaging and the Mechanisms of Antidepressant Action

  2021cites this paper
• Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression

  2021cites this paper
• Economic evaluation in psychiatric pharmacogenomics: a systematic review

  2021cites this paper
• Evaluating of solute carrier family 6 member 4 gene (SLC6A4) promoter polymorphisms with escitalopram plasma levels for precision medicine in major depressive disorder

  2021cites this paper
• Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression.

  2021cites this paper
• Magnetoencephalography Studies in Mood Disorders

  2021cites this paper
• Serotonergic gene-to-gene interaction is associated with mood and GABA concentrations but not with pain-related cerebral processing in fibromyalgia subjects and healthy controls

  2021cites this paper
• Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN-BIND 1 report.

  2021cites this paper
• Association of two specific haplotypes of serotonin transporter gene with fluvoxamine treatment outcomein Iranian patients with obsessive compulsive disorder

  2021cites this paper
• Sexual dysfunction in patients with MDD treated with SSRIs - causes, measurement and prevention

  2021cites this paper
• Adenosine Monophosphate-activated Protein Kinase (AMPK) in serotonin neurons mediates select behaviors during protracted withdrawal from morphine in mice.

  2021cites this paper
• Imaging Glutamatergic and GABAergic Abnormalities in Mood Disorders

  2021cites this paper
• Molecular Imaging of Dopamine and Antipsychotics in Bipolar Disorder

  2021cites this paper
• Brain Imaging of Reward Dysfunction in Unipolar and Bipolar Disorders

  2021cites this paper
• Neurotransmitter Transporters and Their Role in the Pharmacological Actions of Therapeutic and Abused Drugs

  2021cites this paper
• Magnetic Resonance Spectroscopy Investigations of Bioenergy and Mitochondrial Function in Mood Disorders

  2021cites this paper
• Effects of Lithium on Brain Structure in Bipolar Disorder

  2021cites this paper
• Resting-State Functional Connectivity in Unipolar Depression

  2021cites this paper
• Imaging Genetic and Epigenetic Markers in Mood Disorders

  2021cites this paper
• Neuroanatomical Findings in Bipolar Disorder

  2021cites this paper
• Neuroimaging Studies of Effects of Psychotherapy in Depression

  2021cites this paper
• Molecular Imaging of Depressive Disorders

  2020cites this paper
• Brainstem expression of SLC6A4, HTR2C, NGF, BDNF, TRKANGF, TRKBBDNF and P75NTR following paternal alcohol exposure in the male mouse

  2020cites this paper
• Cocaine Dependence

  2020cites this paper
• Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antidepressant response in major depressive disorder.

  2020cites this paper
• Depression and inflammation: implications for cardiovascular disease

  2020cites this paper
• Genome plasticity and neuropsychiatric disorders

  2020cites this paper
• Population frequency and risk factors for depression in Eastern Ukraine

  2020cites this paper
• Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction.

  2020cites this paper
• Pharmacogenomics of treatment response in major depressive disorder

  2020cites this paper
• Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study

  2020cites this paper
• Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population

  2020cites this paper
• The search for personalized antidepressant treatments: what have we learned and where are we going.

  2020cites this paper
• Enrichment Environment Positively Influences Depression- and Anxiety-Like Behavior in Serotonin Transporter Knockout Rats through the Modulation of Neuroplasticity, Spine, and GABAergic Markers

  2020cites this paper
• Pharmacokinetic considerations for current state-of-the-art antidepressants

  2019cites this paper
• Biomarker-Based Treatment Selection: A Precision Medicine Approach for Depression

  2019cites this paper
• Affective Disorders and Gender Differences

  2019cites this paper
• Neurodevelopmental roles and the serotonin hypothesis of autism spectrum disorder

  2019cites this paper
• Transcranial Direct Current Stimulation in Psychiatry: Mood Disorders, Schizophrenia and Other Psychiatric Diseases

  2019cites this paper
• Frontal-limbic brain processes in healthy individuals : environmental, epigenetic and behavioral correlates

  2019cites this paper
• Pharmacogenomics in Psychiatric Disorders

  2019cites this paper
• Novel susceptibility genes were found in a targeted sequencing of stroke patients with or without depression in the Chinese Han population.

  2019cites this paper
• Affective Disorders and Gender Differences

  2019cites this paper
• Neurodegenerative Disease Caregivers' 5-HTTLPR Genotype Moderates the Effect of Patients' Empathic Accuracy Deficits on Caregivers' Well-Being.

  2019cites this paper
• Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

  2019cites this paper
• Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity

  2019cites this paper
• The involvement of sleep in the relationship between the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and depression: A systematic review.

  2019cites this paper
• Associations of the serotonin transporter promoter polymorphism (5‐HTTLPR) with bipolar disorder and treatment response: A systematic review and meta‐analysis

  2019cites this paper
• Depression in neurodegenerative diseases: Common mechanisms and current treatment options.

  2019cites this paper
• Genetic variants in major depressive disorder: From pathophysiology to therapy

  2019cites this paper
• To be submitted to Expert Review of Molecular Diagnostics Blood Biomarkers and Treatment response in Major Depression

  2019cites this paper
• [The serotonin syndrome: An updated literature review].

  2019cites this paper
• Personalized TMS: role of RNA genotyping

  2019cites this paper
• Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder

  2019cites this paper
• Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial

  2019cites this paper
• Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

  2018cites this paper